GMED240517C62500
- 2.07
- -0.28-11.91%
Globus Medical Newsroom
Globus Medical Raised to Overweight From Neutral by Piper Sandler
Globus Medical Raised to Overweight From Neutral by Piper Sandler
Express News | Piper Sandler Upgrades Globus Medical to Overweight, Raises Price Target to $80
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Abivax SA Sponsored ADR (ABVX)
Express News | NYSE Order Imbalance 148887.0 Shares on Buy Side
Globus Medical(GMED.US) Director Sells US$4.09 Million in Common Stock
$Globus Medical(GMED.US)$ Director Lemaitre Dan sold 63,300 shares of common stock on May 10, 2024 at an average price of $64.6133 for a total value of $4.09 million.Source: Announcement What is state
Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing
Dan Lemaitre, Director, on May 10, 2024, sold 63,300 shares in Globus Medical (GMED) for $4,090,022. SEC Filing: https://www.sec.gov/Archives/edgar/data/1237831/000095017024059787/xslF345X03/ownership
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings
Globus Medical, Inc.'s (NYSE:GMED) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed strength. However, we think the company is showing some signs that things
Express News | Globus Medical Inc : Morgan Stanley Raises Target Price to $67.00 From $57.00
Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating
Globus Medical (GMED) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $55 to $85. Price: 62.33, Change: -2.40, Percent Change: -3.70
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Globus Medical (GMED) and DENTSPLY SIRONA (XRAY)
Truist Financial Keeps Their Hold Rating on Globus Medical (GMED)
Globus Medical(GMED.US) Director Sells US$1.3 Million in Common Stock
$Globus Medical(GMED.US)$ Director Davidar David D sold 20,000 shares of common stock on May 8, 2024 at an average price of $65 for a total value of $1.3 million.Source: Announcement What is statement
Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing
David D Davidar, Director, on May 08, 2024, sold 20,000 shares in Globus Medical (GMED) for $1,300,000. Following the Form 4 filing with the SEC, Davidar has control over a total of 772,242 shares of
Form 144 | Globus Medical(GMED.US) Director Proposes to Sell 3.39 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $Globus Medical(GMED.US)$ Director Lemaitre Dan intends to sell 52,500 shares of its common stock on May 10, with a total market value of approximately $3.39 million.
Form 144 | Globus Medical(GMED.US) Director Proposes to Sell 693.78K in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $Globus Medical(GMED.US)$ Director Lemaitre Dan intends to sell 10,800 shares of its common stock on May 10, with a total market value of approximately $693.78K. Sou
Express News | NYSE Order Imbalance 52918.0 Shares on Buy Side
Globus Medical Is Maintained at Overweight by Barclays
Globus Medical Is Maintained at Overweight by Barclays
Globus Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 37.35% Barclays $83 → $85 Maintains Overweight 05/08/2024 1.8% BTIG $60 → $63 Maintains Buy 05/
Express News | Globus Medical Inc : Barclays Raises Target Price to $85 From $83
Barclays Reaffirms Their Buy Rating on Globus Medical (GMED)